Capturing side-effect of medication to identify persons at risk of delirium

Aging Clinical and Experimental Research

Volumn 22, Issue 5-6, 2010, Pages 456-458

  Lauretani, Fulvio ^a   Ceda, Gian Paolo ^a   Maggio, Marcello ^a   Nardelli, Anna ^a   Saccavini, Marsilio ^a   Ferrucci, Luigi ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Cause and prevention; Cholinergic deficiency; Delirium

Indexed keywords

LEVODOPA; TRAMADOL;

AGED; AGED HOSPITAL PATIENT; ANALGESIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DELIRIUM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; MEDICAL EXAMINATION; PAIN; PARKINSONISM; PATIENT IDENTIFICATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL EXAMINATION; PREFRONTAL CORTEX; PRESCRIPTION; RIGIDITY; RISK ASSESSMENT; VASCULAR LESION;

EID: 79955413521     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/BF03324944     Document Type: Article

References (11)

1. Young J, Inouye SK. Delirium in older people. BMJ 2007; 334: 842-6. (Pubitemid 46706931)
2. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 2008; 63: 764-72.
3. Coffman JA, Dilsaver SC. Cholinergic mechanisms in delirium. Am J Psychiatry 1988; 145: 382-3.
4. Cummings JL, Back C. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am J Geriatr Psychiatry 1998; 6: S64-78.
5. Minger SL, Esiri MM, McDonald B et al. Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology 2000; 55: 1460-7.
6. Inouye SK, Ferrucci L. Elucidating the pathophysiology of delir ium and the interrelationship of delirium and dementia. J Gerontol A Biol Sci Med Sci 2006; 61: 1277-80. (Pubitemid 46151069)
7. Lauretani F, Maggio M, Nardelli A, Saccavini M, Ceda G. Should 3,4-dihydroxy-L-phenylalanine be used routinely in vascular Parkinson? J Am Geriatr Soc 2008; 56: 1977-8.
8. Cancelli I, Valentinis L, Merlino G, Valente M, Gigli GL. Drugs with anticholinergic properties as a risk factor for psychosis in pa tients affected by Alzheimer's disease. Clin Pharmacol Ther 2008; 84: 63-8. (Pubitemid 351861486)
9. Cancelli I, Beltrame M, Gigli GL, Valente M. Drugs with anticholinergic properties: cognitive and neuropsychiatrie side-effects in elderly patients. Neurol Sci 2009; 30: 87-92.
10. Hirano H, Day J, Fibiger HC. Serotonergic regulation of acetylcholine release in rat frontal cortex. J Neurochem 1995; 65: 1139-45.
11. Shiga Y, Minami K, Shiraishi M et al. The inhibitory effects of tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M(3) receptors. Anesth Analg 2002; 95: 1269-73.